Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Paul Bunn to T-Lymphocytes

This is a "connection" page, showing publications Paul Bunn has written about T-Lymphocytes.

 
Connection Strength
 
 
 
0.609
 
  1. Boven E, Lindmo T, Mitchell JB, Bunn PA. Selective cytotoxicity of 125I-labeled monoclonal antibody T101 in human malignant T cell lines. Blood. 1986 Feb; 67(2):429-35.
    View in: PubMed
    Score: 0.038
  2. Bunn PA, Carrasquillo JA, Keenan AM, Schroff RW, Foon KA, Hsu SM, Gazdar AF, Reynolds JC, Perentesis P, Larson SM. Imaging of T-cell lymphoma by radiolabelled monoclonal antibody. Lancet. 1984 Nov 24; 2(8413):1219-21.
    View in: PubMed
    Score: 0.035
  3. Posner LE, Fossieck BE, Eddy JL, Bunn PA. Septicemic complications of the cutaneous T-cell lymphomas. Am J Med. 1981 Aug; 71(2):210-6.
    View in: PubMed
    Score: 0.028
  4. Haynes BF, Metzgar RS, Minna JD, Bunn PA. Phenotypic characterization of cutaneous T-cell lymphoma. Use of monoclonal antibodies to compare with other malignant T cells. N Engl J Med. 1981 May 28; 304(22):1319-23.
    View in: PubMed
    Score: 0.028
  5. Bunn PA, Edelson R, Ford SS, Shackney SE. Patterns of cell proliferation and cell migration in the S?zary syndrome. Blood. 1981 Mar; 57(3):452-63.
    View in: PubMed
    Score: 0.027
  6. Broder S, Bunn PA. Cutaneous T-cell lymphomas. Semin Oncol. 1980 Sep; 7(3):310-31.
    View in: PubMed
    Score: 0.026
  7. Bunn PA, Huberman MS, Whang-Peng J, Schechter GP, Guccion JG, Matthews MJ, Gazdar AF, Dunnick NR, Fischmann AB, Ihde DC, Cohen MH, Fossieck B, Minna JD. Prospective staging evaluation of patients with cutaneous T-cell lymphomas. Demonstration of a high frequency of extracutaneous dissemination. Ann Intern Med. 1980 Aug; 93(2):223-30.
    View in: PubMed
    Score: 0.026
  8. Dora D, Rivard C, Yu H, Bunn P, Suda K, Ren S, Lueke Pickard S, Laszlo V, Harko T, Megyesfalvi Z, Moldvay J, Hirsch FR, Dome B, Lohinai Z. Neuroendocrine subtypes of small cell lung cancer differ in terms of immune microenvironment and checkpoint molecule distribution. Mol Oncol. 2020 09; 14(9):1947-1965.
    View in: PubMed
    Score: 0.026
  9. Bunn PA, Whang-Peng J, Carney DN, Schlam ML, Knutsen T, Gazdar AF. DNA content analysis by flow cytometry and cytogenetic analysis in mycosis fungoides and S?zary syndrome. J Clin Invest. 1980 Jun; 65(6):1440-8.
    View in: PubMed
    Score: 0.026
  10. Bunn PA, Carney DN. Treatment of cutaneous T-cell lymphoma. J Dermatol Surg Oncol. 1980 May; 6(5):383-7.
    View in: PubMed
    Score: 0.026
  11. Carney DN, Bunn PA. Manifestations of cutaneous T-cell lymphoma. J Dermatol Surg Oncol. 1980 May; 6(5):369-77.
    View in: PubMed
    Score: 0.026
  12. Lamberg SI, Bunn PA. Cutaneous T-cell lymphomas. Summary of the Mycosis Fungoides Cooperative Group-National Cancer Institute Workshop. Arch Dermatol. 1979 Sep; 115(9):1103-5.
    View in: PubMed
    Score: 0.025
  13. Kaplan EH, Rosen ST, Norris DB, Roenigk HH, Saks SR, Bunn PA. Phase II study of recombinant human interferon gamma for treatment of cutaneous T-cell lymphoma. J Natl Cancer Inst. 1990 Feb 07; 82(3):208-12.
    View in: PubMed
    Score: 0.013
  14. Bunn PA. Diagnostic factors in intermediate and high-grade lymphomas: pathologic, immunologic, and clinical. J Clin Oncol. 1988 Jul; 6(7):1073-5.
    View in: PubMed
    Score: 0.011
  15. Foon KA, Roth MS, Bunn PA. Interferon therapy of non-Hodgkin's lymphoma. Cancer. 1987 Feb 01; 59(3 Suppl):601-4.
    View in: PubMed
    Score: 0.010
  16. Dmitrovsky E, Matthews MJ, Bunn PA, Schechter GP, Makuch RW, Winkler CF, Eddy J, Sausville EA, Ihde DC. Cytologic transformation in cutaneous T cell lymphoma: a clinicopathologic entity associated with poor prognosis. J Clin Oncol. 1987 Feb; 5(2):208-15.
    View in: PubMed
    Score: 0.010
  17. Bunn PA, Ihde DC, Foon KA. Recombinant interferon alfa-2a, an active agent in advanced cutaneous T-cell lymphomas. Int J Cancer Suppl. 1987; 1:9-13.
    View in: PubMed
    Score: 0.010
  18. Foon KA, Roth MS, Bunn PA. Alpha interferon treatment of low-grade B-cell non-Hodgkin's lymphomas, cutaneous T-cell lymphomas, and chronic lymphocytic leukemia. Semin Oncol. 1986 Sep; 13(3 Suppl 2):35-42.
    View in: PubMed
    Score: 0.010
  19. Kuefler PR, Bunn PA. Adult T cell leukaemia/lymphoma. Clin Haematol. 1986 Aug; 15(3):695-726.
    View in: PubMed
    Score: 0.010
  20. Bunn PA, Ihde DC, Foon KA. The role of recombinant interferon alfa-2a in the therapy of cutaneous T-cell lymphomas. Cancer. 1986 Apr 15; 57(8 Suppl):1689-95.
    View in: PubMed
    Score: 0.010
  21. Bunn PA, Foon KA. Therapeutic options in advanced cutaneous T cell lymphomas: a role for interferon alfa-2a (Roferon-A). Semin Oncol. 1985 Dec; 12(4 Suppl 5):18-24.
    View in: PubMed
    Score: 0.009
  22. Sausville EA, Worsham GF, Matthews MJ, Makuch RW, Fischmann AB, Schechter GP, Gazdar AF, Bunn PA. Histologic assessment of lymph nodes in mycosis fungoides/S?zary syndrome (cutaneous T-cell lymphoma): clinical correlations and prognostic import of a new classification system. Hum Pathol. 1985 Nov; 16(11):1098-109.
    View in: PubMed
    Score: 0.009
  23. Sidi Y, Edwards NL, Winkler C, Bunn P, Mitchell BS. Differential metabolism of deoxyribonucleosides by leukaemic T cells of immature and mature phenotype. Br J Haematol. 1985 Sep; 61(1):125-34.
    View in: PubMed
    Score: 0.009
  24. Bertness V, Kirsch I, Hollis G, Johnson B, Bunn PA. T-cell receptor gene rearrangements as clinical markers of human T-cell lymphomas. N Engl J Med. 1985 Aug 29; 313(9):534-8.
    View in: PubMed
    Score: 0.009
  25. Rosen ST, Radvany R, Roenigk H, Terasaki PI, Bunn PA. Human leukocyte antigens in cutaneous T cell lymphoma. J Am Acad Dermatol. 1985 Mar; 12(3):531-4.
    View in: PubMed
    Score: 0.009
  26. Bunn PA, Foon KA, Ihde DC, Longo DL, Eddy J, Winkler CF, Veach SR, Zeffren J, Sherwin S, Oldham R. Recombinant leukocyte A interferon: an active agent in advanced cutaneous T-cell lymphomas. Ann Intern Med. 1984 Oct; 101(4):484-7.
    View in: PubMed
    Score: 0.009
  27. Blayney DW, Blattner WA, Robert-Guroff M, Jaffe ES, Fisher RI, Bunn PA, Patton MG, Rarick HR, Gallo RC. The human T-cell leukemia-lymphoma virus in the southeastern United States. JAMA. 1983 Aug 26; 250(8):1048-52.
    View in: PubMed
    Score: 0.008
  28. Bunn PA, Schechter GP, Jaffe E, Blayney D, Young RC, Matthews MJ, Blattner W, Broder S, Robert-Guroff M, Gallo RC. Clinical course of retrovirus-associated adult T-cell lymphoma in the United States. N Engl J Med. 1983 Aug 04; 309(5):257-64.
    View in: PubMed
    Score: 0.008
  29. Gallo RC, Kalyanaraman VS, Sarngadharan MG, Sliski A, Vonderheid EC, Maeda M, Nakao Y, Yamada K, Ito Y, Gutensohn N, Murphy S, Bunn PA, Catovsky D, Greaves MF, Blayney DW, Blattner W, Jarrett WF, zur Hausen H, Seligmann M, Brouet JC, Haynes BF, Jegasothy BV, Jaffe E, Cossman J, Broder S, Fisher RI, Golde DW, Robert-Guroff M. Association of the human type C retrovirus with a subset of adult T-cell cancers. Cancer Res. 1983 Aug; 43(8):3892-9.
    View in: PubMed
    Score: 0.008
  30. Winkler CF, Bunn PA. Cutaneous T-cell lymphoma: a review. Crit Rev Oncol Hematol. 1983; 1(1):49-92.
    View in: PubMed
    Score: 0.008
  31. Munson D, Bunn PA, Schechter GP. Fc receptor-defined T-lymphocyte subpopulations in patients with cutaneous T-cell lymphoma. J Invest Dermatol. 1982 Nov; 79(5):317-21.
    View in: PubMed
    Score: 0.008
  32. Kalyanaraman VS, Sarngadharan MG, Bunn PA, Minna JD, Gallo RC. Antibodies in human sera reactive against an internal structural protein of human T-cell lymphoma virus. Nature. 1981 Nov 19; 294(5838):271-3.
    View in: PubMed
    Score: 0.007
  33. Haynes BF, Bunn P, Mann D, Thomas C, Eisenbarth GS, Minna J, Fauci AS. Cell surface differentiation antigens of the malignant T cell in Sezary syndrome and mycosis fungoides. J Clin Invest. 1981 Feb; 67(2):523-30.
    View in: PubMed
    Score: 0.007
  34. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A. 1980 Dec; 77(12):7415-9.
    View in: PubMed
    Score: 0.007
  35. Carney DN, Bunn PA, Schechter GP, Gazdar AF. Lymphocyte transformation in patients with cutaneous T-cell lymphomas. Int J Cancer. 1980 Nov 15; 26(5):535-42.
    View in: PubMed
    Score: 0.007
  36. Myrie C, Bunn PA, Edelson RL. A clinico-histopathologic atlas. J Dermatol Surg Oncol. 1980 May; 6(5):391-400.
    View in: PubMed
    Score: 0.006
  37. Huberman MS, Bunn PA, Matthews MJ, Ihde DC, Gazdar AF, Cohen MH, Minna JD. Hepatic involvement in the cutaneous T-cell lymphomas: results of percutaneous biopsy and peritoneoscopy. Cancer. 1980 Apr 01; 45(7):1683-8.
    View in: PubMed
    Score: 0.006
  38. Gazdar AF, Carney DN, Bunn PA, Russell EK, Jaffe ES, Schechter GP, Guccion JG. Mitogen requirements for the in vitro propagation of cutaneous T-cell lymphomas. Blood. 1980 Mar; 55(3):409-17.
    View in: PubMed
    Score: 0.006
  39. Gazdar AF, Carney DN, Russell EK, Schechter GP, Bunn PA. In vitro growth of cutaneous T-cell lymphomas. Cancer Treat Rep. 1979 Apr; 63(4):587-90.
    View in: PubMed
    Score: 0.006
  40. Guccion JG, Fischmann AB, Bunn PA, Schechter GP, Patterson RH, Matthews MJ. Ultrastructural appearance of cutaneous T cell lymphomas in skin, lymph nodes, and peripheral blood. Cancer Treat Rep. 1979 Apr; 63(4):565-70.
    View in: PubMed
    Score: 0.006
  41. Schechter GP, Bunn PA, Fischmann AB, Matthews MJ, Guccion J, Soehnlen F, Munson D, Minna JD. Blood and lymph node T lymphocytes in cutaneous T cell lymphoma: evaluation by light microscopy. Cancer Treat Rep. 1979 Apr; 63(4):571-4.
    View in: PubMed
    Score: 0.006
  42. Kuzel TM, Gilyon K, Springer E, Variakojis D, Kaul K, Bunn PA, Evans L, Roenigk HH, Rosen ST. Interferon alfa-2a combined with phototherapy in the treatment of cutaneous T-cell lymphoma. J Natl Cancer Inst. 1990 Feb 07; 82(3):203-7.
    View in: PubMed
    Score: 0.003
  43. Keenan AM, Weinstein JN, Carrasquillo JA, Bunn PA, Reynolds JC, Foon KA, Smarte NC, Ghosh B, Fejka RM, Larson SM, et al. Immunolymphoscintigraphy and the dose dependence of 111In-labeled T101 monoclonal antibody in patients with cutaneous T-cell lymphoma. Cancer Res. 1987 Nov 15; 47(22):6093-9.
    View in: PubMed
    Score: 0.003
  44. Carrasquillo JA, Mulshine JL, Bunn PA, Reynolds JC, Foon KA, Schroff RW, Perentesis P, Steis RG, Keenan AM, Horowitz M, et al. Indium-111 T101 monoclonal antibody is superior to iodine-131 T101 in imaging of cutaneous T-cell lymphoma. J Nucl Med. 1987 Mar; 28(3):281-7.
    View in: PubMed
    Score: 0.003
  45. Carrasquillo JA, Bunn PA, Keenan AM, Reynolds JC, Schroff RW, Foon KA, Su MH, Gazdar AF, Mulshine JL, Oldham RK, et al. Radioimmunodetection of cutaneous T-cell lymphoma with 111In-labeled T101 monoclonal antibody. N Engl J Med. 1986 Sep 11; 315(11):673-80.
    View in: PubMed
    Score: 0.003
  46. Broder S, Bunn PA, Jaffe ES, Blattner W, Gallo RC, Wong-Staal F, Waldmann TA, DeVita VT. NIH conference. T-cell lymphoproliferative syndrome associated with human T-cell leukemia/lymphoma virus. Ann Intern Med. 1984 Apr; 100(4):543-57.
    View in: PubMed
    Score: 0.002
  47. Jaffe ES, Blattner WA, Blayney DW, Bunn PA, Cossman J, Robert-Guroff M, Gallo RC. The pathologic spectrum of adult T-cell leukemia/lymphoma in the United States. Human T-cell leukemia/lymphoma virus-associated lymphoid malignancies. Am J Surg Pathol. 1984 Apr; 8(4):263-75.
    View in: PubMed
    Score: 0.002
  48. Blayney DW, Jaffe ES, Blattner WA, Cossman J, Robert-Guroff M, Longo DL, Bunn PA, Gallo RC. The human T-cell leukemia/lymphoma virus associated with American adult T-cell leukemia/lymphoma. Blood. 1983 Aug; 62(2):401-5.
    View in: PubMed
    Score: 0.002
  49. Robert-Guroff M, Kalyanaraman VS, Blattner WA, Popovic M, Sarngadharan MG, Maeda M, Blayney D, Catovsky D, Bunn PA, Shibata A, Nakao Y, Ito Y, Aoki T, Gallo RC. Evidence for human T cell lymphoma-leukemia virus infection of family members of human T cell lymphoma-leukemia virus positive T cell leukemia-lymphoma patients. J Exp Med. 1983 Jan 01; 157(1):248-58.
    View in: PubMed
    Score: 0.002
  50. Whang-Peng J, Bunn PA, Knutsen T, Matthews MJ, Schechter G, Minna JD. Clinical implications of cytogenetic studies in cutaneous T-cell lymphoma (CTCL). Cancer. 1982 Oct 15; 50(8):1539-53.
    View in: PubMed
    Score: 0.002
  51. Blatt J, Bunn PA, Carney DD, Reaman G, Soprey P, Poplack DG. Purine pathway enzymes in the circulating malignant cells of patients with cutaneous T-cell lymphoma. Br J Haematol. 1982 Sep; 52(1):97-104.
    View in: PubMed
    Score: 0.002
  52. Brigham BA, Bunn PA, Horton JE, Schechter GP, Wahl LM, Bradley EC, Dunnick NR, Matthews MJ. Skeletal manifestations in cutaneous T-cell lymphomas. Arch Dermatol. 1982 Jul; 118(7):461-7.
    View in: PubMed
    Score: 0.002
  53. Posner LE, Robert-Guroff M, Kalyanaraman VS, Poiesz BJ, Ruscetti FW, Fossieck B, Bunn PA, Minna JD, Gallo RC. Natural antibodies to the human T cell lymphoma virus in patients with cutaneous T cell lymphomas. J Exp Med. 1981 Aug 01; 154(2):333-46.
    View in: PubMed
    Score: 0.002
  54. Whang-Peng J, Bunn P, Knutsen T, Schechter GP, Gazdar AF, Matthews MJ, Minna JD. Cytogenetic abnormalities in patients with cutaneous T-cell lymphomas. Cancer Treat Rep. 1979 Apr; 63(4):575-80.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)